"Arthritis, Rheumatoid" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A chronic systemic disease, primarily of the joints, marked by inflammatory changes in the synovial membranes and articular structures, widespread fibrinoid degeneration of the collagen fibers in mesenchymal tissues, and by atrophy and rarefaction of bony structures. Etiology is unknown, but autoimmune mechanisms have been implicated.
| Descriptor ID |
D001172
|
| MeSH Number(s) |
C05.550.114.154 C05.799.114 C17.300.775.099 C20.111.199
|
| Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "Arthritis, Rheumatoid".
Below are MeSH descriptors whose meaning is more specific than "Arthritis, Rheumatoid".
This graph shows the total number of publications written about "Arthritis, Rheumatoid" by people in this website by year, and whether "Arthritis, Rheumatoid" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1995 | 2 | 0 | 2 |
| 1996 | 1 | 1 | 2 |
| 1998 | 1 | 0 | 1 |
| 1999 | 4 | 0 | 4 |
| 2000 | 1 | 0 | 1 |
| 2001 | 4 | 0 | 4 |
| 2002 | 2 | 0 | 2 |
| 2003 | 2 | 0 | 2 |
| 2004 | 4 | 0 | 4 |
| 2005 | 7 | 0 | 7 |
| 2006 | 12 | 2 | 14 |
| 2007 | 6 | 1 | 7 |
| 2008 | 8 | 1 | 9 |
| 2009 | 10 | 1 | 11 |
| 2010 | 10 | 1 | 11 |
| 2011 | 9 | 5 | 14 |
| 2012 | 10 | 1 | 11 |
| 2013 | 7 | 2 | 9 |
| 2014 | 6 | 2 | 8 |
| 2015 | 13 | 1 | 14 |
| 2016 | 10 | 3 | 13 |
| 2017 | 12 | 7 | 19 |
| 2018 | 9 | 1 | 10 |
| 2019 | 7 | 1 | 8 |
| 2020 | 5 | 0 | 5 |
| 2021 | 9 | 0 | 9 |
| 2022 | 21 | 0 | 21 |
| 2023 | 9 | 0 | 9 |
| 2024 | 3 | 2 | 5 |
| 2025 | 2 | 0 | 2 |
To return to the timeline,
click here.
Below are the most recent publications written about "Arthritis, Rheumatoid" by people in Profiles.
-
Unique methotrexate polyglutamates distributions in peripheral blood mononuclear cells of rheumatoid arthritis patients: Development and validation of a UPLC-MS/MS method. J Pharm Biomed Anal. 2025 Sep 01; 262:116882.
-
Disease activity of rheumatoid arthritis and kidney function decline: a large prospective registry study. Ann Rheum Dis. 2025 Feb; 84(2):201-209.
-
A compartmentalized microfluidic platform to investigate immune cells cross-talk in rheumatoid arthritis. Biofabrication. 2024 Oct 24; 17(1).
-
Trends in the use of biologic disease-modifying antirheumatic drugs in patients with rheumatoid arthritis and recently diagnosed colorectal, lung, or prostate cancer. Clin Rheumatol. 2024 Nov; 43(11):3301-3312.
-
Survival in patients with rheumatoid arthritis and early breast cancer treated with tumor necrosis factor inhibitors. Breast Cancer. 2024 Nov; 31(6):1059-1070.
-
Interleukin-6 receptor antagonists in pregnancy: a reason for cautious optimism. Lancet Rheumatol. 2024 Sep; 6(9):e592-e593.
-
2023 American College of Rheumatology (ACR)/American College of Chest Physicians (CHEST) Guideline for the Screening and Monitoring of Interstitial Lung Disease in People with Systemic Autoimmune Rheumatic Diseases. Arthritis Rheumatol. 2024 Aug; 76(8):1201-1213.
-
Cachexia in preclinical rheumatoid arthritis: Longitudinal observational study of thigh magnetic resonance imaging from osteoarthritis initiative cohort. J Cachexia Sarcopenia Muscle. 2024 Oct; 15(5):1823-1833.
-
Rheumatoid arthritis and changes on spirometry by smoking status in two prospective longitudinal cohorts. RMD Open. 2024 06 17; 10(2).
-
A narrative review of the comparative safety of disease-modifying anti-rheumatic drugs used for the treatment of rheumatoid arthritis. Expert Opin Drug Saf. 2024 Jun; 23(6):687-714.